Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boris Freidlin

Showing results (11-20 of 118) with videos related to

Pageof 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2013
Adaptive randomization versus interim monitoringBoris Freidlin, Edward L Korn
Statistics in Medicine|May 23, 2024
Design of randomized clinical trials with a binary endpoint: Conditional versus unconditional analyses of a two-by-two tableEdward L Korn, Boris Freidlin
Journal of the National Cancer Institute|November 30, 2022
Improving precision oncology through better designs and reporting of biomarker-driven randomized clinical trialsPatricia M LoRusso, Boris Freidlin
Journal of the National Cancer Institute|January 14, 2011
Re: Designing a randomized clinical trial to evaluate personalized medicine: a new approach based on risk predictionRichard M Simon, Boris Freidlin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2010
Outcome--adaptive randomization: is it useful?Edward L Korn, Boris Freidlin
The Lancet. Oncology|January 5, 2025
Non-inferiority trials: tyranny or good governance?Boris Freidlin, Edward L Korn
Clinical Trials (London, England)|August 5, 2017
RejoinderBoris Freidlin, Edward L Korn
Genetic Testing|February 3, 2005
A note on appropriate use of statistical tests of mutation rates from ordered groupsJoseph L Gastwirth, Boris Freidlin
Statistics in Medicine|January 10, 2002
A testing procedure for survival data with few respondersBoris Freidlin, Edward L Korn
Statistics in Medicine|March 1, 2007
Release of data from an ongoing randomized clinical trial for sample size adjustment or planningBoris Freidlin, Edward L Korn
Pageof 12

Showing results (11-20 of 118) with videos related to

Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2013
Adaptive randomization versus interim monitoringBoris Freidlin, Edward L Korn
Statistics in Medicine|May 23, 2024
Design of randomized clinical trials with a binary endpoint: Conditional versus unconditional analyses of a two-by-two tableEdward L Korn, Boris Freidlin
Journal of the National Cancer Institute|November 30, 2022
Improving precision oncology through better designs and reporting of biomarker-driven randomized clinical trialsPatricia M LoRusso, Boris Freidlin
Journal of the National Cancer Institute|January 14, 2011
Re: Designing a randomized clinical trial to evaluate personalized medicine: a new approach based on risk predictionRichard M Simon, Boris Freidlin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2010
Outcome--adaptive randomization: is it useful?Edward L Korn, Boris Freidlin
The Lancet. Oncology|January 5, 2025
Non-inferiority trials: tyranny or good governance?Boris Freidlin, Edward L Korn
Clinical Trials (London, England)|August 5, 2017
RejoinderBoris Freidlin, Edward L Korn
Genetic Testing|February 3, 2005
A note on appropriate use of statistical tests of mutation rates from ordered groupsJoseph L Gastwirth, Boris Freidlin
Statistics in Medicine|January 10, 2002
A testing procedure for survival data with few respondersBoris Freidlin, Edward L Korn
Statistics in Medicine|March 1, 2007
Release of data from an ongoing randomized clinical trial for sample size adjustment or planningBoris Freidlin, Edward L Korn
Pageof 12